- Nov 30, 2020
New immunotherapy shows promise against rare childhood cancer
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer. Read more: https://www.eurekalert.org/pub_releases/2020-11/ucl-nis112520.php
- Nov 27, 2020
Pediatric cancer treatment can cause long-term dental, bone, skin, liver, immunity issues
Late effects of pediatric cancer treatment may not be readily apparent to primary care clinicians or specialists who follow childhood cancer survivors over the long term. Read more: https://www.healio.com/news/hematology-oncology/20201124/pediatric-cancer-treatment-can-cause-longterm-dental-bone-skin-liver-immunity-issues
- Nov 26, 2020
Helping Children Cope With Side Effects From Cancer Treatment
The following are some approaches to help relieve symptoms at home among children undergoing anticancer treatment. However, all symptoms should be reported to the oncology care team, and parents should call the clinic if symptoms are new, if they worsen, or if they are severe. Read more: https://www.cancertherapyadvisor.com/home/tools/fact-sheets/children-cancer-symptoms-coping-fact-sheet-patient/
- Nov 25, 2020
Study offers new clues for treating brain cancer in children
Brain tumors are among the most common — and the most deadly — cancers among children. A new paper, published Wednesday in the journal Cell, explores the intricacies of how cancers of the brain operate in children and proffers tantalizing clues about how they may be treated. Read more: https://www.statnews.com/2020/11/25/study-new-clues-treating-brain-cancer-children/
- Nov 18, 2020
Breakthrough in childhood brain cancer will save lives
Research by Newcastle University, UK, has revealed that experts can identify the time, nature and outcome of medulloblastoma relapse from the biology of the disease at diagnosis and the initial therapy received. Read more: https://medicalxpress.com/news/2020-11-breakthrough-childhood-brain-cancer.html
- Nov 9, 2020
Trials Underway Using Experimental CAR T-Cell Therapy For Deadly Childhood Brain Cancer
"Diffuse intrinsic pontine glioma (DIPG) is one of the hardest to treat cancers and most children diagnosed with it die within a year, with standard therapies failing to provide any chance of long-term survival. Now two clinical trials are underway to assess the effectiveness of a type of cell-based therapy called CAR T-cells in tackling the disease and another, related disease with a similarly poor prognosis, called diffuse midline glioma (DMG)." Read more: https://www
- Nov 6, 2020
Anti-depressant repurposed to treat childhood cancer
A new study has found that a commonly prescribed anti-depressant may halt growth of a type of cancer known as childhood sarcoma, at least in mice and laboratory cell experiments. Read more: https://eurekalert.org/pub_releases/2020-11/ki-art110520.php
- Nov 3, 2020
Reduced-intensity therapy effective for children with very low-risk ALL
Children with very low-risk acute lymphoblastic leukemia can be treated successfully with reduced-intensity therapy, according to results of a study published in Blood. Read more: https://www.healio.com/news/hematology-oncology/20201030/reducedintensity-therapy-effective-for-children-with-very-lowrisk-all